Literature DB >> 17703256

A p.R870H mutation in the beta-cardiac myosin heavy chain 7 gene causes familial hypertrophic cardiomyopathy in several members of an Indian family.

Murali D Bashyam1, Gorinabele R Savithri, Munimanda Gopikrishna, Calambur Narasimhan.   

Abstract

Familial hypertrophic cardiomyopathy is an autosomal dominant genetic disorder characterized mainly by left ventricular hypertrophy and myocyte disarray; it is the most common cause of sudden death in otherwise healthy individuals. More than 270 mutations in genes encoding the cardiac sarcomere have been identified. Attempts to establish a genotype-phenotype correlation for each of the mutations have not been highly successful. It has been suggested that additional genetic loci, as well as nongenetic factors such as lifestyle, gender and age, may play a role in modulating the clinical presentation of the disease. The p.R870H mutation has been identified as the cause of familial hypertrophic cardiomyopathy in an Indian family. The results indicate that the disease phenotype varied among various affected members of the family, and the variation may be attributed to factors, such as gender and gene dosage.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17703256      PMCID: PMC2651383          DOI: 10.1016/s0828-282x(07)70828-0

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  4 in total

1.  The in vitro motility activity of beta-cardiac myosin depends on the nature of the beta-myosin heavy chain gene mutation in hypertrophic cardiomyopathy.

Authors:  G Cuda; L Fananapazir; N D Epstein; J R Sellers
Journal:  J Muscle Res Cell Motil       Date:  1997-06       Impact factor: 2.698

2.  Homozygous mutation in cardiac troponin T: implications for hypertrophic cardiomyopathy.

Authors:  C Y Ho; H M Lever; R DeSanctis; C F Farver; J G Seidman; C E Seidman
Journal:  Circulation       Date:  2000-10-17       Impact factor: 29.690

Review 3.  Molecular genetics of familial hypertrophic cardiomyopathy (FHC).

Authors:  Murali D Bashyam; Gorinabele R Savithri; Murugapiran S Kumar; Calambur Narasimhan; Pratibha Nallari
Journal:  J Hum Genet       Date:  2003       Impact factor: 3.172

4.  A myosin missense mutation, not a null allele, causes familial hypertrophic cardiomyopathy.

Authors:  H Nishi; A Kimura; H Harada; Y Koga; K Adachi; K Matsuyama; T Koyanagi; S Yasunaga; T Imaizumi; H Toshima
Journal:  Circulation       Date:  1995-06-15       Impact factor: 29.690

  4 in total
  4 in total

1.  A low prevalence of MYH7/MYBPC3 mutations among familial hypertrophic cardiomyopathy patients in India.

Authors:  Murali D Bashyam; Guroji Purushotham; Ajay K Chaudhary; Katika Madhumohan Rao; Vishal Acharya; Tabrez A Mohammad; Hampapathalu A Nagarajaram; Vuppaladadhiam Hariram; Calambur Narasimhan
Journal:  Mol Cell Biochem       Date:  2011-09-29       Impact factor: 3.396

2.  The MYH7 p.R787H mutation causes hypertrophic cardiomyopathy in two unrelated families.

Authors:  G Purushotham; K Madhumohan; Mohammad Anwaruddin; Ha Nagarajaram; Vuppaladadhiam Hariram; Calambur Narasimhan; Murali D Bashyam
Journal:  Exp Clin Cardiol       Date:  2010

3.  Genotype phenotype correlations of cardiac beta-myosin heavy chain mutations in Indian patients with hypertrophic and dilated cardiomyopathy.

Authors:  Taranjit Singh Rai; Shamim Ahmad; Ajay Bahl; Monica Ahuja; Tarunveer Singh Ahluwalia; Balvinder Singh; K K Talwar; Madhu Khullar
Journal:  Mol Cell Biochem       Date:  2008-10-25       Impact factor: 3.396

Review 4.  Recent Advances in the Molecular Genetics of Familial Hypertrophic Cardiomyopathy in South Asian Descendants.

Authors:  Jessica Kraker; Shiv Kumar Viswanathan; Ralph Knöll; Sakthivel Sadayappan
Journal:  Front Physiol       Date:  2016-10-28       Impact factor: 4.566

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.